{
 "name": "神隆",
 "slug": "tw-1789",
 "aliases": [
  "台灣神隆股份有限公司",
  "SPT",
  "1789"
 ],
 "ticker": "1789",
 "industry": "生技醫療業",
 "website": "https://www.scinopharm.com/tw",
 "summary": "神隆（1789）是上市的生技醫療類股公司，1997 年成立，2011 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "台灣神隆股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "SPT",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "2011-09-29",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "1997-11-11",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "羅智先",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "盧麗安",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 7907392220,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "https://www.scinopharm.com/tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 309439,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔數值、單位與as_of保留；2026-10-23核對官方115年9月申報資料（出表1151017），百分比按原檔保留兩位小數。原source為valueledger次級網址混入中文說明，改為可直接開啟的一手API。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 74.45,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔數值、單位與as_of保留；2026-10-23核對官方115年9月申報資料（出表1151017），百分比按原檔保留兩位小數。原source為valueledger次級網址混入中文說明，改為可直接開啟的一手API。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": -5.71,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔數值、單位與as_of保留；2026-10-23核對官方115年9月申報資料（出表1151017），百分比按原檔保留兩位小數。原source為valueledger次級網址混入中文說明，改為可直接開啟的一手API。"
  },
  {
   "claim": "管線：Glatiramer Acetate（醋酸格拉替雷注射劑）",
   "value": "多發性硬化症｜已取得美國藥證並於2026年3月出貨｜美國",
   "unit": "",
   "as_of": "2026-08-17",
   "source": "https://www.scinopharm.com/news-detail/144/",
   "note": "僅記來源所述取證與出貨；未從新聞發布日推定藥證核准日期。"
  },
  {
   "claim": "管線：Bortezomib（注射劑）",
   "value": "多發性骨髓瘤｜已取得台灣藥證並於2026年6月納入健保｜台灣",
   "unit": "",
   "as_of": "2026-08-17",
   "source": "https://www.scinopharm.com/news-detail/144/",
   "note": "此公告未列藥證完整核准日；許可證號可見官網已開發產品頁，但不將公告日當核准日。"
  },
  {
   "claim": "管線：Clofarabine（克羅拉濱注射劑）",
   "value": "急性淋巴母細胞白血病｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-19",
   "source": "https://www.scinopharm.com/news-detail/141/",
   "note": "來源稱2025年取得；不將新聞發布日期當精確核准日期。"
  },
  {
   "claim": "管線：SPT1470（學名未公開）",
   "value": "癌症標靶藥物｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  },
  {
   "claim": "管線：SPT1499（學名未公開）",
   "value": "癌症標靶藥物｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  },
  {
   "claim": "管線：SPT1515（學名未公開）",
   "value": "婦科相關疾病｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  },
  {
   "claim": "管線：SPT1516（學名未公開）",
   "value": "婦科相關疾病｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  },
  {
   "claim": "管線：SPT1517（學名未公開）",
   "value": "代謝疾病｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  },
  {
   "claim": "管線：SPC1523（學名未公開）",
   "value": "中樞神經系統相關疾病｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  },
  {
   "claim": "管線：SPT1526（學名未公開）",
   "value": "代謝疾病｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  },
  {
   "claim": "管線：SPT1532（學名未公開）",
   "value": "泌尿系統疾病｜規劃開發（臨床階段未公開）｜未公開",
   "unit": "",
   "as_of": "2026-03-31",
   "source": "https://www.scinopharm.com/investor_document-detail/355/",
   "note": "年報明列New products on drawing board，僅披露疾病領域；未公開確切適應症、臨床期別與申請市場。as_of依封面Printed on 03 31, 2026；不把生產地當開發地區。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-23",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-1789.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}